Screener
Mirum Pharmaceuticals, Inc. MIRM Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Gross Carrying Value | Accumulated Amortization | Net Carrying Amount | Weighted-Average Remaining Amortization Period (Years) |
|---|---|---|---|---|
| Commercial milestones | $94,000 | $(15,527) | $78,473 | 11.1 |
| Developed technology | 226,620 | (57,759) | 168,861 | 9.3 |
| Assembled workforce | 970 | (916) | 54 | 0.2 |
| Total intangible assets | $321,590 | $(74,202) | $247,388 | 9.8 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s intangibles (net)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported intangibles (net) of $247.39M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s intangibles (net) increased by 4.0% year-over-year, from $237.87M to $247.39M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Mirum Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude